Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

Whether you turn red when drinking alcohol, dislike certain smells, or metabolize drugs differently from others, the ...

Lurie Children's Hospital officially announced an expansion of research with the $11 million from Don and Anne Edwards, who ...

With the MiSeq™ i100 Series, Illumina continues to set the highest standards.Advancements in system design, sequencing chemistry, and data analysis deliverthe simplest, fastest benchtop sequencing and ...

Researchers demonstrated that it is feasible to encode executable payloads into synthetic DNA that, once sequenced and ...

The DNA Diagnostics Market is set to surge from USD 13.07 billion in 2024 to USD 21.69 billion by 2030, growing at a CAGR of ...

Abu Dhabi (EAD) has partnered with M42 for a genome sequencing project at the Plant Genetic Resources Centre. The project ...

In the past twenty years, major technological advances in extracting and analyzing DNA have transformed the ability to ...

The next generation sequencing market offers significant opportunities by enhancing the diagnosis and treatment of chronic ...

Tuberculosis (TB) is one of the oldest and deadliest infectious diseases we know. It commonly impacts the lungs, but can also affect other areas of the body like the spine, brain or kidneys.

The cost of decoding our genetic makeup has plummeted. Just because it’s affordable doesn’t necessarily mean it’s worth doing ...